Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 25, 2011

View Archived Issues

New cDNA library vaccine cures experimental prostate cancer

Plant-produced protein blocks transmission of Plasmodium falciparum

Investigation of thiostrepton uncovers new possible target for breast cancer therapy

Taisho synthesizes new vasopressin V1B receptor antagonists

KalVista receives funding to develop new treatment for diabetic macular edema

Merck & Co. presents novel Lck inhibitors

Spinifex Pharmaceuticals obtains funding to expand phase II EMA-401 program

Novacta Biosystems discloses novel lantibiotic-based agents

Chinese company prepares novel tyrosine-protein kinase inhibitors

Pharmaneuroboost receives IRB approval for phase III PNB-01 trial

Theron Pharmaceuticals patents novel muscarinic acetylcholine M3 receptor antagonists

FDA awards fast track status to Pharmasset's PSI-938

Allergan prepares novel prostanoid EP2 receptor agonists

Phase III study of treprostinil diethanolamine does not meet primary endpoint

Clavis Pharma expands pivotal phase III elacytarabine trial

FDA approves Botox for new indication

RegeneRx completes enrollment in phase II dry eye syndrome study

Pharmaxis resubmits data for E.U. Bronchitol marketing application

FDA issues communication regarding high doses of citalopram

Peregrine reports survival data from bavituximab plus docetaxel breast cancer study

NICE issues recommendation regarding golimumab

SIGA receives NIH grant to develop antiviral drug

Senesco Technologies and Mayo Clinic finalize agreement to study SNS01-T

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...